Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review

Movement of tumours, mostly by respiration, has been a major problem for treating lung cancer, liver tumours and other locations in the abdomen and thorax. Organ motion is indeed one component of geometrical uncertainties that includes delineation and target definition uncertainties, microscopic dis...

Full description

Bibliographic Details
Main Authors: De Ruysscher, Dirk, Sterpin, Edmond, Haustermans, Karin, Depuydt, Tom
Format: Online
Language:English
Published: MDPI 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586762/
id pubmed-4586762
recordtype oai_dc
spelling pubmed-45867622015-10-06 Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review De Ruysscher, Dirk Sterpin, Edmond Haustermans, Karin Depuydt, Tom Review Movement of tumours, mostly by respiration, has been a major problem for treating lung cancer, liver tumours and other locations in the abdomen and thorax. Organ motion is indeed one component of geometrical uncertainties that includes delineation and target definition uncertainties, microscopic disease and setup errors. At present, minimising motion seems to be the easiest to implement in clinical practice. If combined with adaptive approaches to correct for gradual anatomical variations, it may be a practical strategy. Other approaches such as repainting and tracking could increase the accuracy of proton therapy delivery, but advanced 4D solutions are needed. Moreover, there is a need to perform clinical studies to investigate which approach is the best in a given clinical situation. The good news is that existing and emerging technology and treatment planning systems as will without doubt lead in the forthcoming future to practical solutions to tackle intra-fraction motion in proton therapy. These developments may also improve motion management in photon therapy as well. MDPI 2015-06-29 /pmc/articles/PMC4586762/ /pubmed/26132317 http://dx.doi.org/10.3390/cancers7030829 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author De Ruysscher, Dirk
Sterpin, Edmond
Haustermans, Karin
Depuydt, Tom
spellingShingle De Ruysscher, Dirk
Sterpin, Edmond
Haustermans, Karin
Depuydt, Tom
Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review
author_facet De Ruysscher, Dirk
Sterpin, Edmond
Haustermans, Karin
Depuydt, Tom
author_sort De Ruysscher, Dirk
title Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review
title_short Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review
title_full Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review
title_fullStr Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review
title_full_unstemmed Tumour Movement in Proton Therapy: Solutions and Remaining Questions: A Review
title_sort tumour movement in proton therapy: solutions and remaining questions: a review
description Movement of tumours, mostly by respiration, has been a major problem for treating lung cancer, liver tumours and other locations in the abdomen and thorax. Organ motion is indeed one component of geometrical uncertainties that includes delineation and target definition uncertainties, microscopic disease and setup errors. At present, minimising motion seems to be the easiest to implement in clinical practice. If combined with adaptive approaches to correct for gradual anatomical variations, it may be a practical strategy. Other approaches such as repainting and tracking could increase the accuracy of proton therapy delivery, but advanced 4D solutions are needed. Moreover, there is a need to perform clinical studies to investigate which approach is the best in a given clinical situation. The good news is that existing and emerging technology and treatment planning systems as will without doubt lead in the forthcoming future to practical solutions to tackle intra-fraction motion in proton therapy. These developments may also improve motion management in photon therapy as well.
publisher MDPI
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586762/
_version_ 1613481363254542336